Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immix Biopharma, Inc.

1.58
-0.0700-4.24%
Post-market: 1.580.00000.00%19:36 EDT
Volume:18.66K
Turnover:30.02K
Market Cap:43.80M
PE:-2.07
High:1.69
Open:1.58
Low:1.57
Close:1.65
Loading ...
Jun 14, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 08, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K/A [Amend] - Current report
Jan 18, 2023

Major Issues Report

8-K - Current report
Jan 09, 2023

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2022

Major Issues Report

8-K - Current report
May 27, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 27, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals